Pharmacology
Escitalopram oxalate improved insomnia by targeting SLC6A4 to regulate the hypothalamic-pituitary-adrenal axis.
Xin Gu, Jing An, Mingxue Zhang, Hongyan Zhang, Zhan Lou, Bu Wang
Published: 202610.1159/000550304
Abstract
BACKGROUND: Escitalopram oxalate (ESC) was extensively reported to improve insomnia in patients with depression/anxiety. The serotonin transporter gene (SLC6A4) was involved in regulating insomnia. However, it is still unclear whether ESC improves in…
Preview only. Read the full abstract at the source